Protein Phosphatases in Lymphocyte Signal Transduction
淋巴细胞信号转导中的蛋白磷酸酶
基本信息
- 批准号:7204167
- 负责人:
- 金额:$ 35.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAntibody FormationApoptosisAutoimmunityBiochemical GeneticsCell Cycle ProgressionCell Cycle RegulationCell ProliferationCell Proliferation RegulationCell physiologyCellsCentrosomeCollagen ArthritisDiseaseEvaluationExperimental ArthritisExperimental Autoimmune EncephalomyelitisFutureGene TargetingGenetic RecombinationImmune System DiseasesImmune responseImmunizationInfectionInflammatory ResponseInkIntegration Host FactorsKnock-outKnockout MiceLeadLymphocyteMAPK8 geneMediatingModelingMusNF-kappa BOkadaic AcidPathway interactionsPhosphoric Monoester HydrolasesPhysiologicalProtein Phosphatase 2A Regulatory Subunit PR53Protein Serine/Threonine PhosphataseProtein phosphataseRetroviridaeRoleSignal PathwaySignal TransductionStructure of germinal center of lymph nodeSystemT-Cell ActivationT-Cell DevelopmentT-Cell ProliferationT-LymphocyteTestingTh1/Th2 Differentiation PathwayTherapeutic AgentsTransgenic Micebasecell mediated immune responsedesignembryonic stem cellin vivoleukemia/lymphomamouse modelnovel
项目摘要
DESCRIPTION (provided by applicant): INK and NF-kappaB are involved in T-cell activation/differentiation, inflammatory responses, apoptosis, and cell proliferation. Protein phosphatase 4 (PP4) is an okadaic acid-sensitive protein serine/threonine phosphatase. To date, little is known about the functions of PP4. Our results provide the first evidence for the existence of PP4/JNK and PP4/ NF-kappaB modules as a new paradigm for the control of the signaling pathways in T cells. Understanding the underlying mechanisms of PP4-mediated T-cell signal transduction will lead to the discovery of the functions of PP4. This application plans to study the roles of PP4 in T-cell signaling and T-cell mediated immune responses. To unveil novel physiological functions of PP4 in T cells, we will generate PP4 knockout cells and mice using the Cre-foxP recombination system and Lck-Cre transgenic mice. The approaches are: (i) to understand the roles PP4 in T-cell proliferation, apoptosis, differentiation, centrosome function, and signaling using various biochemical and genetic approaches, and (ii) to study the in vivo functions of PP4 in Th1/Th2 differentiation, immune responses, and autoirnmunity. Ultimately, we plan to dissect various PP4-mediated signaling pathways in immune responses, leukemia/lymphoma, and immunological diseases. Our future understanding of host factors involved in the PP4-mediated lymphocyte signaling pathways will provide information fundamental to the discovery, design, and evaluation of effective intracellular therapeutic agents for leukemia/lymphoma, infections, and immunological disorders such as autoimmunity. The specific aims are: Aim 1. Study the roles of PP4 in T-cell proliferation, apoptosis, differentiation, and signaling using PP4 conditional knockout mice and cells. Aim 2. Study in vivo functions of PP4 in T-cell mediated immune responses and autoimmunity using Tcell specific PP4 conditional knockout mice.
描述(由申请人提供):INK和NF-κ B参与T细胞活化/分化、炎症反应、凋亡和细胞增殖。蛋白磷酸酶4(PP 4)是冈田酸敏感的蛋白丝氨酸/苏氨酸磷酸酶。迄今为止,人们对PP 4的功能知之甚少。我们的研究结果为PP 4/JNK和PP 4/ NF-kappaB模块的存在提供了第一个证据,作为控制T细胞信号通路的新范例。了解PP 4介导的T细胞信号转导的潜在机制将有助于发现PP 4的功能。本申请计划研究PP 4在T细胞信号传导和T细胞介导的免疫应答中的作用。为了揭示PP 4在T细胞中的新的生理功能,我们将使用Cre-foxP重组系统和Lck-Cre转基因小鼠产生PP 4敲除细胞和小鼠。这些方法是:(i)利用各种生物化学和遗传学方法了解PP 4在T细胞增殖、凋亡、分化、中心体功能和信号传导中的作用;(ii)研究PP 4在Th 1/Th 2分化、免疫应答和自身免疫中的体内功能。最终,我们计划解剖各种PP 4介导的信号通路在免疫反应,白血病/淋巴瘤和免疫疾病。我们未来对PP 4介导的淋巴细胞信号通路中所涉及的宿主因素的了解将为白血病/淋巴瘤、感染和免疫性疾病(如自身免疫)的有效细胞内治疗剂的发现、设计和评价提供基本信息。具体目标是:目标1。使用PP 4条件性敲除小鼠和细胞研究PP 4在T细胞增殖、凋亡、分化和信号传导中的作用。目标二。使用T细胞特异性PP 4条件性敲除小鼠研究PP 4在T细胞介导的免疫应答和自身免疫中的体内功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tse-Hua Tan其他文献
Tse-Hua Tan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tse-Hua Tan', 18)}}的其他基金
Protein Phosphatases in Lymphocyte Signal Transduction
淋巴细胞信号转导中的蛋白磷酸酶
- 批准号:
6964971 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases in Lymphocyte Signal Transduction
淋巴细胞信号转导中的蛋白磷酸酶
- 批准号:
7082143 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
PP4 and IGF-1 Signaling in Breast Tumorigenesis
乳腺肿瘤发生中的 PP4 和 IGF-1 信号转导
- 批准号:
6864953 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases in Lymphocyte Signal Transduction
淋巴细胞信号转导中的蛋白磷酸酶
- 批准号:
7614172 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases in Lymphocyte Signal Transduction
淋巴细胞信号转导中的蛋白磷酸酶
- 批准号:
7408064 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
PP4 and IGF-1 Signaling in Breast Tumorigenesis
乳腺肿瘤发生中的 PP4 和 IGF-1 信号转导
- 批准号:
7054698 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases and Proinflammatory Cytokines
蛋白磷酸酶和促炎细胞因子
- 批准号:
6891095 - 财政年份:2002
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases and Proinflammatory Cytokines
蛋白磷酸酶和促炎细胞因子
- 批准号:
7046096 - 财政年份:2002
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases and Proinflammatory Cytokines
蛋白磷酸酶和促炎细胞因子
- 批准号:
6485662 - 财政年份:2002
- 资助金额:
$ 35.56万 - 项目类别:
Protein Phosphatases and Proinflammatory Cytokines
蛋白磷酸酶和促炎细胞因子
- 批准号:
6732605 - 财政年份:2002
- 资助金额:
$ 35.56万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 35.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 35.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 35.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 35.56万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 35.56万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 35.56万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 35.56万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 35.56万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 35.56万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 35.56万 - 项目类别: